选择语言

Biotinylated Cynomolgus / Rhesus macaque 4-1BB / TNFRSF9 Protein, Avitag™,His Tag (MALS verified)

用户评价
货号-规格
价格
Qty.
41B-C82E9-25ug
¥3675.00
41B-C82E9-200ug
¥14490.00
合计0件 产品金额¥ 0

产品详情

  • 分子别名(Synonym)

    TNFRSF9,4-1BB,CD137,CDw137,ILA

  • 表达区间及表达系统(Source)

    Biotinylated Cynomolgus / Rhesus macaque 4-1BB, Avitag,His Tag (41B-C82E9) is expressed from human 293 cells (HEK293). It contains AA Leu 24 - Gln 186 (Accession # A9YYE7-1).

    Predicted N-terminus: Leu 24

    Request for sequence
  • 蛋白结构(Molecular Characterization)

    4-1BB Structure

    This protein carries an Avi tag (Avitag™) at the C-terminus, followed by a polyhistidine tag.

    The protein has a calculated MW of 21.8 kDa. The protein migrates as 30-40 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • 标记(Labeling)

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • 蛋白标记度(Protein Ratio)

    Passed as determined by the HABA assay / binding ELISA.

  • 纯度(Purity)

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • 制剂(Formulation)

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 重构方法(Reconstitution)

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • 存储(Storage)

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

数据展示

  • 电泳(SDS-PAGE)

    4-1BB SDS-PAGE

    Biotinylated Cynomolgus / Rhesus macaque 4-1BB, Avitag,His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

  • SEC-MALS

    4-1BB SEC-MALS

    The purity of Biotinylated Cynomolgus / Rhesus macaque 4-1BB, Avitag,His Tag (Cat. No. 41B-C82E9) is more than 90% and the molecular weight of this protein is around 27-41 kDa verified by SEC-MALS.

    Report
  • 活性(Bioactivity)-ELISA

     4-1BB ELISA

    Immobilized Biotinylated Cynomolgus / Rhesus macaque 4-1BB, Avitag,His Tag (Cat. No. 41B-C82E9) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Cynomolgus 4-1BB Ligand, Fc Tag (Cat. No. 41L-C5254) with a linear range of 0.3-2 ng/mL (QC tested).

    Protocol
  •  4-1BB ELISA

    Immobilized Cynomolgus 4-1BB Ligand, Fc Tag (Cat. No. 41L-C5254) at 5 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus / Rhesus macaque 4-1BB, Avitag,His Tag (Cat. No. 41B-C82E9) with a linear range of 0.3-20 ng/mL (Routinely tested).

    Protocol
  •  4-1BB ELISA

    Immobilized Human 4-1BB Ligand, Fc Tag at 5 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus / Rhesus macaque 4-1BB, Avitag,His Tag (Cat. No. 41B-C82E9) with a linear range of 0.6-20 ng/mL (Routinely tested).

    Protocol
  •  4-1BB ELISA

    Immobilized Utomilumab at 1 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus / Rhesus macaque 4-1BB, Avitag,His Tag (Cat. No. 41B-C82E9) with a linear range of 0.3-10 ng/mL (Routinely tested).

    Protocol

用户评价
发表评论

背景介绍

4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.

前沿进展

 
药物研发进展
  • 英文全称:

    Tumor necrosis factor receptor superfamily member 9

  • 中文全称:

    肿瘤坏死因子受体超家族成员9

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    74 详情

  • 最高研发阶段:

    临床二期

联系我们
项目合作
查看更多项目
  • 产品基础信息
  • 产品详情
  • 数据展示
  • 用户评价
  • 背景介绍